03.09.2010 - One Nucleus announced the appointment of Dr Alan Palmer as a Director. Alan is co-founder and currently Chief Scientific Officer for MS Therapeutics Ltd and has 30 years experience in the biotechnology sector in roles spanning academia, research and industry. Alan (…)
[Read article]
[Source: Bionity.com]
STOCKHOLM, September 2, 2010 /PRNewswire/ - Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions. Three new analyses of subgroups from (…)
[Read article]
[Source: BioSpace]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/66a1b1/philippines_pharma) has announced the addition of the "Philippines Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Philippines Pharmaceuticals and (…)
[Read article]
[Source: Business Wire]
TARRYTOWN, N.Y.-(BUSINESS WIRE)-Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) announced today that the Company will present preclinical findings for its humanized monoclonal antibodies that bind and neutralize the potentially life-threatening toxins produced by the (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Elan Corporation, plc ( Elan ) (NYSE: ELN) announced today that Elan s wholly-owned subsidiaries, Elan Finance public limited company ( Elan Finance ) and Elan Finance Corp. ( Elan Corp and together with Elan Finance, the Issuers ), (…)
[Read article]
[Source: Business Wire]
London - ImmunoSolv, a leading Edinburgh-based private company developer of immunology platform technology, is pleased to announce that it has completed a merger with Aberdeen-based Grampian BioConsultants Limited ( GBC ). The merged company will retain the name ImmunoSolv (…)
[Read article]
[Source: BioSpace]
OBJECTIVE.: To evaluate changes in vascular and musculoskeletal involvement in subjects in the Scleroderma Lung Study (SLS), a multicenter, double-blind, randomized, controlled trial comparing placebo treatment to oral cyclophosphamide for 1 year in systemic sclerosis (SSc) (…)
[Read article]
[Source: NCBI PubMed]
Magnetoreception can play a substantial role in long distance navigation by animals. I hypothesize that locomotion guided by a magnetic compass sense could also play a role in short distance navigation. Animals identify mates, prey, or other short distance navigational goals (…)
[Read article]
[Source: NCBI PubMed]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/360241/best_practices_in) has announced the addition of the "Best Practices in Working with Patient Advocacy Groups: Building Effective Relationships" report to their offering. Best (…)
[Read article]
[Source: Business Wire]
Most active pharmaceutical ingredients (API) exhibit particle size distributions with some degrees of asymmetry deviating from log-normality. A new log-skew-normal (L-S-N) distribution model is proposed for a systematic comparison of the asymmetry effect on content uniformity. (…)
[Read article]
[Source: NCBI PubMed]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/e9e8b4/educating_the_mark) has announced the addition of the "Educating the Market: Creating Value Through Support of Continuing Medical Education 2010" report to their offering. Educating (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/b5aaab/pharmaceutical_new) has announced the addition of the "Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability 2010" report to their (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/81e154/raising_disease_st) has announced the addition of the "Raising Disease State Awareness: Best Practices in Internal Brand Messaging for New Products" report to their offering. (…)
[Read article]
[Source: Business Wire]
Background: 7-Valent pneumococcal conjugate vaccine (PCV7 [Prevnar, Wyeth Pharmaceuticals Inc, Philadelphia, PA], serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F) is effective in preventing vaccine-serotype pneumococcal disease. 13-Valent pneumococcal conjugate vaccine (PCV13) (PCV7 (…)
[Read article]
[Source: NCBI PubMed]
WASHINGTON-(BUSINESS WIRE)-Dr. Sidney Mazel joins global management consulting firm PRTM as executive vice president of transaction services for the health care business group. In this role, he will manage PRTM s acquisition, divestiture and integration services for the firm (…)
[Read article]
[Source: Business Wire]
Despite the eradication of smallpox, there is heightened concern that it could be reintroduced as a result of intentional release of Variola major virus through an act of bioterrorism. The live vaccine that was pivotal in the eradication of smallpox though considered a gold (…)
[Read article]
[Source: NCBI PubMed]
CHARLOTTESVILLE, Virginia, August 23, 2010/- HemoShear LLC today announced the appointments of Robert Ruffolo, Jr., Ph.D., former President of Research and Development for Wyeth Pharmaceuticals, and Kenneth Batchelor, Ph.D., former Senior Vice President for Drug Discovery with (…)
[Read article]
[Source: BioSpace]
The Salk inactivated poliovirus vaccine is one of the most rapid examples of bench-to-bedside translation in medicine. In the span of 6 years, the key basic lab discoveries facilitating the development of the vaccine were made, optimization and safety testing was completed in (…)
[Read article]
[Source: NCBI PubMed]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/22ca66/otc_healthcare_in) has announced the addition of the "OTC Healthcare in the US to 2014" report to their offering. OTC Healthcare in the US to 2014 This databook provides key data (…)
[Read article]
[Source: Business Wire]
Cancer cells are exposed to external and internal stresses by virtue of their unrestrained growth, hostile microenvironment, and increased mutation rate. These stresses impose a burden on protein folding and degradation pathways and suggest a route for therapeutic intervention (…)
[Read article]
[Source: NCBI PubMed]
STUDY DESIGN.: Inflammatory proteins were quantified in bilateral dorsal root ganglions (DRGs) at 1 hour and 1 day using a multiplexed assay after 2 different unilateral nerve root compression injuries. OBJECTIVE.: To quantify cytokines and a chemokine in the DRG after nerve (…)
[Read article]
[Source: NCBI PubMed]
LEIDEN, NETHERLANDS-(Marketwire - August 17, 2010) - PRESS RELEASE Crucell Reports Record Revenues in Second Quarter 2010 Total revenues and other operating income of EUR128.6 million, a 63% growth compared to the same period in 2009 (EUR78.7 million). Strong sales of (…)
[Read article]
[Source: Marketwire]
An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study released today led by a Virginia Commonwealth University researcher. The research compared the effectiveness and safety of the (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/11e326/genzyme_corporatio) has announced the addition of the "Genzyme Corporation: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/89d247/bristolmyers_squi) has announced the addition of the "Bristol-Myers Squibb Co.: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
ScienceDaily (Aug. 16, 2010) An antidepressant can alleviate symptoms of major depression in women experiencing or about to experience menopause, according to a study led by a Virginia Commonwealth University researcher. See Also: Health & Medicine Menopause Mental Health (…)
[Read article]
[Source: ScienceDaily]
BLUE BELL, Pa.-(BUSINESS WIRE)-Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) today reported financial results for the quarter ended June 30, 2010. Total revenue was $1.1 million and $2.5 million for the three and six months ended June 30, 2010, compared to $2.5 million and (…)
[Read article]
[Source: Business Wire]
KING OF PRUSSIA, Pa.-(BUSINESS WIRE)-Worldwide Clinical Trials, Inc., a privately held global contract research organization, today announced that Evelyn Graham has joined the company as Executive Vice President, Global Business Development. With more than 20 years of drug (…)
[Read article]
[Source: Business Wire]
WATERTOWN, Mass.-(BUSINESS WIRE)-Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, announced today that Werner Cautreels, Ph.D. has been appointed as President and Chief Executive Officer. He has also been (…)
[Read article]
[Source: BioSpace]
BLUE BELL, PA August 16, 2010 Inovio Pharmaceuticals, Inc. (NYSE AMEX: INO) today reported financial results for the quarter ended June 30, 2010. Total revenue was $1.1 million and $2.5 million for the three and six months ended June 30, 2010, compared to $2.5 million and $2.9 (…)
[Read article]
[Source: BioSpace]
Extract: Despite more than twenty years of research relating to HIV-1, human immunodeficiency virus type-1, HIV-1 infection remains a public health threat of extraordinary proportions. The World Health Organization estimates that in the year 2003 alone, 4.8 million people were (…)
[Read article]
[Source: NCBI PubMed]
Extract: Since the very beginnings of human medicine, physicians have relied on chemical compounds produced by animals, plants and microorganisms, so-called natural products, to treat diseases. Natural products are directly or indirectly responsible for roughly one-half of all (…)
[Read article]
[Source: NCBI PubMed]
BACKGROUND: This randomized study's aim was to compare the effect of four oral contraceptives (OCs) containing 30 mcg of ethinylestradiol (EE) and different progestogens [drospirenone, (DRSP), chlormadinone acetate (CMA), desogestrel (DSG), gestodene (GSD)] on biochemical and (…)
[Read article]
[Source: NCBI PubMed]
BACKGROUND: Gram-negative Enterobacteriaceae with resistance to carbapenem conferred by New Delhi metallo-beta-lactamase 1 (NDM-1) are potentially a major global health problem. We investigated the prevalence of NDM-1, in multidrug-resistant Enterobacteriaceae in India, (…)
[Read article]
[Source: NCBI PubMed]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/affcf7/stakeholder_opinio) has announced the addition of the "Stakeholder Opinions: Vaccines in Emerging Markets (Latin America) - Opportunities in Brazil, Mexico and Argentina" report to (…)
[Read article]
[Source: Business Wire]
Indian authorities say it is unfair to associate the superbug that has surfaced in Great Britain to India, because a significant number of bacteria carrying the NDM-1 gene (DNA code) have been reported in several different countries, including Brazil, the USA, Canada, Puerto (…)
[Read article]
[Source: Medical News Today]
LEIDEN, NETHERLANDS-(Marketwire - August 11, 2010) - Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL) (SWISS: CRX) today announces its intention to participate in an international Phase I clinical trial in the United States and Africa of a combination (…)
[Read article]
[Source: Marketwire]
LEIDEN, NETHERLANDS-(Marketwire - August 11, 2010) - Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL) (SWISS: CRX) today announced that it will release its financial results for the second quarter 2010 on Tuesday August 17, 2010 at 07:45 AM Central (…)
[Read article]
[Source: BioSpace]
BRIDGEWATER, N.J.-(BUSINESS WIRE)-CorMedix Inc. ( CorMedix ) (NYSE Amex: CRMD), a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of Cardiorenal disease, today announced the appointment of Robert D. (…)
[Read article]
[Source: Business Wire]
OBJECTIVE: To quantify the negative impact that major depressive disorder (MDD) has on quality of life, disability, and work, family, and overall psychosocial functioning. Available scales that assess these areas of impairment as they relate to patients with MDD are described. (…)
[Read article]
[Source: NCBI PubMed]
Am J Psychiatry. |-| Burt VK, Bernstein C, Rosenstein WS, Altshuler LL. |-| Dr. Burt has served as consultant or adviser to, or on the speakers bureau of, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Noven Pharmaceuticals, Takeda Pharmaceuticals, and Wyeth-Ayerst. Dr. (…)
[Read article]
[Source: NCBI PubMed]
Secondary drug screening methods are described for determining the relative degree of non-covalent binding between drug candidates and a protein of therapeutic interest by gel centrifugation chromatography using GPC spin columns for isolating the protein-drug complexes, under (…)
[Read article]
[Source: NCBI PubMed]